| __timestamp | Insmed Incorporated | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 56292000 | 581800000 |
| Thursday, January 1, 2015 | 74277000 | 671900000 |
| Friday, January 1, 2016 | 122721000 | 876700000 |
| Sunday, January 1, 2017 | 109749000 | 857900000 |
| Monday, January 1, 2018 | 145283000 | 822200000 |
| Tuesday, January 1, 2019 | 131711000 | 778200000 |
| Wednesday, January 1, 2020 | 181157000 | 512600000 |
| Friday, January 1, 2021 | 272744000 | 681000000 |
| Saturday, January 1, 2022 | 397518000 | 662200000 |
| Sunday, January 1, 2023 | 571011000 | 910700000 |
Data in motion
In the ever-evolving landscape of biopharmaceuticals, research and development (R&D) expenses are a critical indicator of a company's commitment to innovation. Over the past decade, Viatris Inc. and Insmed Incorporated have demonstrated contrasting strategies in their R&D investments.
Viatris Inc. has consistently allocated a significant portion of its resources to R&D, with expenses peaking in 2023 at approximately 910 million USD. This represents a 56% increase from 2014, underscoring their dedication to advancing healthcare solutions.
Conversely, Insmed Incorporated has shown a remarkable surge in R&D spending, growing nearly tenfold from 2014 to 2023. This aggressive investment strategy highlights their focus on pioneering treatments and expanding their therapeutic pipeline.
As these companies continue to innovate, their R&D expenditures offer a glimpse into the future of medical breakthroughs.
Comparing Innovation Spending: Alnylam Pharmaceuticals, Inc. and Viatris Inc.
Who Prioritizes Innovation? R&D Spending Compared for Genmab A/S and Insmed Incorporated
R&D Spending Showdown: Viatris Inc. vs Intra-Cellular Therapies, Inc.
Analyzing R&D Budgets: Viatris Inc. vs Rhythm Pharmaceuticals, Inc.
R&D Spending Showdown: Viatris Inc. vs Amneal Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Viatris Inc. vs Arrowhead Pharmaceuticals, Inc.
Comparing Innovation Spending: Viatris Inc. and Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Insmed Incorporated and Amneal Pharmaceuticals, Inc.
R&D Spending Showdown: Insmed Incorporated vs ImmunityBio, Inc.
Research and Development: Comparing Key Metrics for Insmed Incorporated and Protagonist Therapeutics, Inc.
R&D Insights: How Insmed Incorporated and Wave Life Sciences Ltd. Allocate Funds
Research and Development Expenses Breakdown: Insmed Incorporated vs Mesoblast Limited